International clinical trials setting for rare cancers: organisational and regulatory constraints—the EORTC perspective

Rare diseases are a serious public health problem that presents unique challenges to many countries. There is no internationally accepted definition for rare diseases. Patients suffering from rare cancers often face challenges, including late or incorrect diagnoses, difficulties finding clinical exp...

Descripción completa

Detalles Bibliográficos
Autores principales: Shash, Emad, Negrouk, Anastassia, Marreaud, Sandrine, Golfinopoulos, Vassilis, Lacombe, Denis, Meunier, Francoise
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660157/
https://www.ncbi.nlm.nih.gov/pubmed/23717342
http://dx.doi.org/10.3332/ecancer.2013.321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660157/
https://www.ncbi.nlm.nih.gov/pubmed/23717342
http://dx.doi.org/10.3332/ecancer.2013.321

Ejemplares similares